Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Capricor Therapeutics (CAPR) Other Operating Expenses (2019 - 2025)

Capricor Therapeutics (CAPR) has 14 years of Other Operating Expenses data on record, last reported at -$6846.0 in Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 99.4% year-over-year to -$6846.0; the TTM value through Sep 2025 reached -$202583.0, up 82.12%, while the annual FY2024 figure was -$112805.0, 1767.32% down from the prior year.
  • Other Operating Expenses reached -$6846.0 in Q3 2025 per CAPR's latest filing, up from -$150673.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $17389.0 in Q2 2023 and bottomed at -$1.1 million in Q3 2024.
  • Average Other Operating Expenses over 5 years is -$94903.7, with a median of -$5388.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: soared 526.84% in 2022, then plummeted 20917.13% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$36467.0 in 2021, then grew by 6.04% to -$34266.0 in 2022, then surged by 98.09% to -$653.0 in 2023, then crashed by 6801.07% to -$45064.0 in 2024, then surged by 84.81% to -$6846.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were -$6846.0 in Q3 2025, -$150673.0 in Q1 2025, and -$45064.0 in Q4 2024.